Research team identifies barriers to annual diabetic retinopathy screening

News
Article

After reviewing information collected on a patient database, the team suggested telephone prompts for patients with mental health concerns, text message reminders, and online educational tools to improve uptake to increase eye screening attendance.

Doctor consoling patient in office Image credit: AdobeStock/StudioRomantic

Image credit: AdobeStock/StudioRomantic

A research team from Great Britain identified factors, such as mental health issues, lack of diabetic eye screening awareness, and transport difficulties, that interfere with attendance at annual screenings by patients with diabetes and evaluated the adherence to guidelines set by the National Institute for Health and Care Excellence (NICE),1 according to the lead author, Upamanyu Leo Chanda, MBBS. He is from the Emergency Department, New Cross Hospital, Royal Wolverhampton Trust, Wolverhampton, England.

The investigators underscored that diabetic retinopathy is the most common sight-threatening complication of diabetes that requires regular monitoring of eyes. NICE recommends annual diabetic eye screening for patients aged 12 and older.

In light of this, the investigators conducted a retrospective clinical audit to determine why patients do not adhere to the guidelines among about 9,000 patients in a practice.

Study methods and findings

Chanda and colleagues used the SystmOne patient database to identify patients who had missed eye screening during the previous 15 and 36 months; those in the second group were considered non-attenders.

The investigators explained, “A survey of every third patient who missed screening in the last 15 months highlighted mental health issues, lack of DES awareness, and transport difficulties as primary reasons for non-attendance. The DES uptake rates recorded at the practice were 77.2% (n=465) for the 15-month cohort and 83.6% (n=503) for the 36-month cohort, exceeding the NHS DES target of 75%.” The authors reported their findings in Cureus.

Having identified these factors, they proposed the following actions to increase attendance among patients to DES, ie, “telephone prompts for patients with mental health concerns, text message reminders, and online educational tools to improve uptake.”

Among the factors identified, the most prevalent reasons for non-attendance were linked to mental health issues and a lack of knowledge about diabetic retinopathy. They suggested that implementing targeted interventions, such as phone call prompts for patients with known mental health conditions, text message reminders, and online educational tools, should help increase the numbers of patients who attend annual screening examinations.

The investigators also pointed out the need for continuing these efforts to raise awareness and support patients in attending regular screening. “Future re-audits following the implementation of the proposed interventions could help evaluate the impact of these strategies and provide further insights into optimizing diabetic retinopathy screening in primary care practices,” they said.

“Despite standards exceeding the national guidelines, this audit demonstrates the importance of addressing specific barriers to enhance screening rates, potentially increasing the detection of early retinopathy and improving patient outcomes,” Chanda and colleagues stated.

Reference:
  1. Chanda U, Madasu A, Bhardwaj A, et al. Barriers to yearly diabetic retinopathy screening attendance: a retrospective clinical audit. Cureus. 2024;16: e75474. doi:10.7759/cureus.75474; published online December 10, 2024.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Rachelle Lin, OD, MS, FAAO, at CRU Eye Symposium 2025
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Setting the stage in LA: Neda Shamie, MD, on the 19th annual Controversies in Modern Eye Care meeting
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
© 2025 MJH Life Sciences

All rights reserved.